Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

817 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcatheter aortic valve implantation in patients with significant septal hypertrophy.
Beyer M, Demal TJ, Bhadra OD, Linder M, Ludwig S, Grundmann D, Voigtlaender-Buschmann L, Waldschmidt L, Schirmer J, Schofer N, Pecha S, Blankenberg S, Reichenspurner H, Conradi L, Seiffert M, Schaefer A. Beyer M, et al. Among authors: linder m. Clin Res Cardiol. 2024 Mar 11. doi: 10.1007/s00392-024-02432-3. Online ahead of print. Clin Res Cardiol. 2024. PMID: 38466346
Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI.
Grundmann D, Goßling A, Schmidt L, Voigtlaender L, Ludwig S, Linder M, Waldschmidt L, Demal T, Bhadra OD, Schaefer A, Reichenspurner H, Blankenberg S, Conradi L, Westermann D, Seiffert M, Schofer N. Grundmann D, et al. Among authors: linder m. Clin Res Cardiol. 2023 May;112(5):667-676. doi: 10.1007/s00392-023-02154-y. Epub 2023 Jan 19. Clin Res Cardiol. 2023. PMID: 36656376 Free PMC article.
Temporal changes of patient characteristics over 12 years in a single-center transcatheter aortic valve implantation cohort.
Demal TJ, Weimann J, Ojeda FM, Bhadra OD, Linder M, Ludwig S, Grundmann D, Voigtländer L, Waldschmidt L, Schirmer J, Schofer N, Blankenberg S, Reichenspurner H, Conradi L, Seiffert M, Schaefer A. Demal TJ, et al. Among authors: linder m. Clin Res Cardiol. 2023 May;112(5):691-701. doi: 10.1007/s00392-023-02166-8. Epub 2023 Feb 15. Clin Res Cardiol. 2023. PMID: 36792752 Free PMC article.
The Impact of Cerebral Embolic Protection Devices on Characteristics and Outcomes of Stroke Complicating TAVR.
Levi A, Linder M, Seiffert M, Witberg G, Pilgrim T, Tomii D, Barkan YT, Van Mieghem NM, Adrichem R, Codner P, Hildick-Smith D, Arunothayaraj S, Perl L, Finkelstein A, Loewenstein I, De Backer O, Barnea R, Tarantini G, Fovino LN, Vaknin-Assa H, Mylotte D, Wagener M, Webb JG, Akodad M, Colombo A, Mangieri A, Latib A, Kargoli F, Giannini F, Ielasi A, Søndergaard L, Aviram I, Lerman TT, Kheifets M, Auriel E, Kornowski R; ASTRO-TAVI Study Group. Levi A, et al. Among authors: linder m. JACC Cardiovasc Interv. 2024 Mar 11;17(5):666-677. doi: 10.1016/j.jcin.2023.12.033. JACC Cardiovasc Interv. 2024. PMID: 38479966
Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Implantation in Patients with Severe Iliofemoral Calcifications: Expanding Transfemoral Indications.
Linder M, Grundmann D, Kellner C, Demal T, Waldschmidt L, Bhadra O, Ludwig S, Voigtländer L, von der Heide I, Nebel N, Hannen L, Schirmer J, Reichenspurner H, Blankenberg S, Conradi L, Schofer N, Schäfer A, Seiffert M. Linder M, et al. J Clin Med. 2024 Mar 4;13(5):1480. doi: 10.3390/jcm13051480. J Clin Med. 2024. PMID: 38592323 Free PMC article.
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.
Linder M, Ekbom A, Brobert G, Vogtländer K, Balabanova Y, Becattini C, Carrier M, Cohen AT, Coleman CI, Khorana AA, Lee AYY, Psaroudakis G, Abdelgawwad K, Rivera M, Schaefer B, Giunta DH. Linder M, et al. J Thromb Thrombolysis. 2024 May 12. doi: 10.1007/s11239-024-02992-1. Online ahead of print. J Thromb Thrombolysis. 2024. PMID: 38735015
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program.
de Vogel S, Seeger JD, Arana A, Margulis AV, McQuay LJ, Perez-Gutthann S, Hallas J, Kristiansen NS, Linder M, Odsbu I, Suehs B, Xu Y, Uribe C, Appenteng K, Robinson NJ. de Vogel S, et al. Among authors: linder m. Pharmacoepidemiol Drug Saf. 2024 May;33(5):e5799. doi: 10.1002/pds.5799. Pharmacoepidemiol Drug Saf. 2024. PMID: 38680102 Review.
Gasdermin D drives focal Crystalline Thrombotic Microangiopathy by accelerating Immunothrombosis and Necroinflammation.
Watanabe-Kusunoki K, Li C, Bandeira Honda TS, Zhao D, Kusunoki Y, Ku J, Long H, Klaus M, Han C, Braun A, Mammadova-Bach E, Linkermann A, Van Avondt K, Richter M, Soehnlein O, Linder MI, Klein C, Steiger S, Anders HJ. Watanabe-Kusunoki K, et al. Among authors: linder mi. Blood. 2024 Apr 24:blood.2023021949. doi: 10.1182/blood.2023021949. Online ahead of print. Blood. 2024. PMID: 38657197
817 results